Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

The drug combination was safe and showed promise in treating advanced tumors.

Endocrine therapies for cancer significantly increase the risk of hair loss.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.